Package 71610-485-60

{"route": ["ORAL"], "spl_id": "875c3303-147e-4bdf-98f2-8355c056e18f", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["3b18b43c-0de2-4acf-b0d5-f1b601d496de"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-485-30)", "package_ndc": "71610-485-30", "marketing_start_date": "20201110"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-485-60)", "package_ndc": "71610-485-60", "marketing_start_date": "20201110"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-485-70)", "package_ndc": "71610-485-70", "marketing_start_date": "20201110"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-485-80)", "package_ndc": "71610-485-80", "marketing_start_date": "20201110"}], "brand_name": "Topiramate", "product_id": "71610-485_875c3303-147e-4bdf-98f2-8355c056e18f", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71610-485", "generic_name": "Topiramate", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA079162", "marketing_category": "ANDA", "marketing_start_date": "20200907", "listing_expiration_date": "20261231"}